But more and more research has shown that GLP-1s have other benefits, particularly when it comes to weight management, whether you have Type 2 diabetes or not
Wegovy's cardiovascular indication rests on a large outcomes trial described in its label, in which 8,803 patients were exposed to Wegovy for a median of 37.3 months and 8,801 to placebo for a median of 38.6 months, with a primary endpoint of time to first cardiovascular death, nonfatal myocardial infarction or nonfatal stroke
With adequate protein intake and consistent resistance training, research shows that muscle loss can be minimised and strength preserved, even during rapid weight loss
Dosing typically starts low and is titrated upward based on individual tolerance and response
Many patients use the shot for quick, regular top-ups and book a drip when they have the time and want more
It is about helping people stay supported long enough to experience lasting change